Video

China: Evolving Dynamics of the CDMO Landscape

China: Evolving Dynamics of the CDMO Landscape

This webinar originally aired as part of CPhI Discover - 17-28 May 2021

  • An overview of global CDMO markets – positioning, strengths and weaknesses of the Chinese CDMO industry.
  • The Evolution of the Chinese CDMO industry, from CMO to CDMO, from starting materials, intermediates to API, drug substance to drug products, generic drugs to NCE/NME – what innovations are on the horizon?
  • The challenges and opportunities of the Chinese CDMO industry – Growth dynamics, the competitive landscape and regulatory barriers.
  • Building a successful CDMO amidst fierce competition, what are the critical attributes of a successful CMC team?
  • How to strategically build technology platforms and capabilities which meet global compliance standards, what are the key requirements for facilities and systems?
  • Langhua Pharma’s own strategy towards becoming a leading CDMO in China, what does the future look like?
  • Other Content from CPhI